共 50 条
- [42] Re: Intravesical bacillus Calmette-Guerin with Interferon-Alpha versus Intravesical bacillus Calmette-Guerin for Treating Non-Muscle-Invasive Bladder Cancer Editorial Comment [J]. JOURNAL OF UROLOGY, 2018, 199 (03): : 608 - 609
- [45] Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette–Guerin for patients with non-muscle invasive bladder cancer [J]. Cancer Immunology, Immunotherapy, 2018, 67 : 1371 - 1380
- [47] Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule [J]. Indian Journal of Surgical Oncology, 2021, 12 : 796 - 801
- [48] UTILIZATION OF INITIAL CYSTECTOMY VERSUS INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR NON-MUSCLE INVASIVE MICROPAPILLARY UROTHELIAL CARCINOMA OF THE BLADDER [J]. JOURNAL OF UROLOGY, 2021, 206 : E297 - E297
- [49] Methylation status as a predictor of intravesical Bacillus Calmette-Guerin (BCG) immunotherapy response of high grade non-muscle invasive bladder tumor [J]. BIOMEDICAL PAPERS-OLOMOUC, 2017, 161 (02): : 210 - 216